Sildenafil Citrate

CHEMBL1737 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
666.7 g/mol
LogP
Phase
4

A citrate salt form of sildenafil with the same therapeutic properties. Originally developed for heart conditions, this medication relaxes and widens blood vessels by blocking an enzyme called PDE5, increasing blood flow.

Peso molecular

666,7000 g/mol

TPSA

250,00 Ų

Áreas terapéuticas

Mecanismo de acción

Selective PDE5 inhibitor increasing cGMP.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Selective PDE5 inhibitor increasing cGMP.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O

InChI

InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Molecular Formula

C28H38N6O11S

HBD / HBA

5 / 15

Enlaces Rotables

12

Átomos Pesados

46

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A citrate salt form of sildenafil with the same therapeutic properties. Originally developed for heart conditions, this medication relaxes and widens blood vessels by blocking an enzyme called PDE5, increasing blood flow.

Selective PDE5 inhibitor increasing cGMP.

Yes, Sildenafil Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1737. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135413523. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.